...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Prostate Trial
7
Apr 24, 2020 10:26AM
6
Apr 24, 2020 10:50AM

Whoops missed that as was out of country.I know 44 of the patients were enrolled in a continuation trial which is still ongoing.

Share
New Message
Please login to post a reply